Les immunoconjugués en oncologie - Les nouvelles stratégies en développement
Med Sci (Paris), 35 12 (2019) 1043-1053
Published online: 2020-01-06
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions
Bonan Chen, Xiaohong Zheng, Jialin Wu, Guoming Chen, Jun Yu, Yi Xu, William K. K. Wu, Gary M. K. Tse, Ka Fai To and Wei KangMolecular Cancer 24 (1) (2025)
https://doi.org/10.1186/s12943-025-02489-2
Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells
Sara Cherradi, Véronique Garambois, Johanna Marines, et al.Cell & Bioscience 13 (1) (2023)
https://doi.org/10.1186/s13578-023-01015-5
369 (2023)
https://doi.org/10.1016/B978-0-323-90780-4.00022-X
Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment
Asmita Yadav, Sakshi Singh, Harmik Sohi and Shweta DangAAPS PharmSciTech 23 (1) (2021)
https://doi.org/10.1208/s12249-021-02174-9
Antibody–Drug Conjugates: The Last Decade
Nicolas Joubert, Alain Beck, Charles Dumontet and Caroline Denevault-SabourinPharmaceuticals 13 (9) 245 (2020)
https://doi.org/10.3390/ph13090245
Les anticorps, outils de choix pour la chirurgie guidée par fluorescence
André Pèlegrin, Marian Gutowski and Françoise Caillermédecine/sciences 35 (12) 1066 (2019)
https://doi.org/10.1051/medsci/2019207